Target intelligence / Profile preview

Oxysterol-binding protein-related protein 8 (OSBPL8)

Target
OSBPL8
Molecular classification
Lipid transporter, Member of the oxysterol-binding protein family, Contains a pleckstrin homology (PH) domain and OSBP-like sterol-binding domain
01

Overview

Oxysterol-binding protein-related protein 8 is a lipid transporter protein encoded by the OSBPL8 gene. It localizes primarily at membrane contact sites between the endoplasmic reticulum and the plasma membrane, where it facilitates countertransport of lipids: specifically, it exchanges phosphatidylserine and phosphatidylinositol 4-phosphate, helping maintain cellular lipid homeostasis. The protein binds multiple lipid ligands including phosphatidylserine, phosphatidylinositol 4-phosphate, cholesterol, oxysterol, and 25-hydroxycholesterol. It belongs to the oxysterol-binding protein family, characterized by a pleckstrin homology domain and a conserved OSBP-like sterol-binding domain. OSBPL8 is implicated in cellular lipid transfer, membrane organization, and regulation of signaling events such as Ca(2+) flux, with putative relevance in several diseases linked to lipid metabolism and signaling, although it is not currently a major clinical drug target.

Other names
OSBPL8ORP8KIAA1451OSBP10MST120MSTP120OSBP-related protein 8Oxysterol-binding protein-related protein 8ORP-8
02

Mechanism of action

Drugs targeting OSBPL8 would likely modulate lipid transfer and distribution/function at membrane contact sites, especially with respect to phosphatidylserine, phosphoinositides, and cholesterol/oxysterols

03

Biological functions

Lipid transport and countertransport between endoplasmic reticulum (ER) and plasma membraneExchanges phosphatidylserine and phosphatidylinositol 4-phosphate (PI4P)Cholesterol, oxysterol and other lipid bindingRegulates Ca(2+) signaling at membrane contact sites
04

Disease associations

Bardet-Biedl syndromeFundus dystrophyImplicated roles in cancer, metabolic disease, and infectious disease (for the broader OSBP/ORP family; direct, specific disease implications for OSBPL8 are still emerging)
05

Safety considerations

No notable safety concerns or therapeutic challenges directly implicated for OSBPL8-targeted therapy documented; as a regulator of cellular lipid composition, off-target or cascade effects on organelle function and lipid signaling may potentially emerge if targeted clinically
06

Interacting drugs

No specific drugs directly targeting OSBPL8 are documented

1 more in the full profile.

07

Biomarkers

No specific OSBPL8 biomarkers for patient selection or efficacy monitoring are presently established

Beyond the preview

Go deeper on Oxysterol-binding protein-related protein 8 (OSBPL8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxysterol-binding protein-related protein 8 (OSBPL8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call